Internal Medicine, Hematology & Oncology · Turlock, CA
NPI
1962501718
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
880 E Tuolumne Rd, 103
Turlock, CA, 95382
Phone (209) 669-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
2,687 services
Medicare patients, 2024
684
Average age 74
Drug cost, 2024
$7.3M
4,503 prescriptions
Company payments, 2025
$302
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamed E Eldaly was code 99214 (office e&m - established), 1,852 times for 593 patients. In total Mohamed E Eldaly billed 2,687 services in 8 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,852 | 593 | $67.09 | $124K |
| 99215 Office E&M - Established | Facility | 712 | 303 | $105.32 | $75K |
| 99205 Office E&M - New | Facility | 102 | 102 | $133.53 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 14 | 11 | $92.41 | $1,294 |
By year: 2022 $219K for 2,699 services; 2023 $212K for 2,722 services; 2024 $215K for 2,687 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohamed E Eldaly prescribed most often to Medicare patients was Anastrozole, with 502 prescriptions and refills. In total Mohamed E Eldaly wrote 4,503 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 502 | 968 | 102 | $8,391 |
| Calcitonin-Salmon Calcitonin,salmon,synthetic | 295 | 363 | 79 | $18K |
| Ondansetron Odt Ondansetron | 219 | 224 | 133 | $4,736 |
| Pantoprazole Sodium Generic | 216 | 371 | 58 | $1,624 |
| Prochlorperazine Maleate Generic | 188 | 188 | 120 | $1,845 |
| Gabapentin Generic | 168 | 202 | 42 | $3,421 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 141 | 141 | 48 | $4,856 |
| Raloxifene Hcl Generic | 117 | 243 | 28 | $4,689 |
| Imbruvica Ibrutinib | 101 | 101 | 12 | $1.7M |
| Levofloxacin Generic | 99 | 99 | 69 | $336 |
| Xtandi Enzalutamide | 96 | 96 | 13 | $939K |
| Megestrol Acetate Generic | 94 | 104 | 33 | $3,314 |
| Letrozole Generic | 74 | 147 | 16 | $1,244 |
| Azithromycin Generic | 74 | 74 | 51 | $249 |
| Prednisone Generic | 67 | 69 | 19 | $381 |
Brand drugs: - claims; generic drugs: 3,882 claims; opioid claims: 300.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamed E Eldaly $302 ($302 in general payments such as food, travel and fees) from 10 companies. The largest payer was Aveo Pharmaceuticals, Inc. with $89.99.
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 1 | $89.99 |
| Daiichi Sankyo Inc. 4568.T | 2 | $44.03 |
| Servier Pharmaceuticals LLC | 1 | $29.64 |
| Astellas Pharma US Inc 4503.T | 1 | $28.47 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $20.3 |
| Deciphera Pharmaceuticals Inc. | 1 | $19.88 |
| Celgene Corporation BMY | 1 | $19.36 |
| BeiGene USA, Inc. ONC | 1 | $18.47 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.45 |
| Merck Sharp & Dohme LLC MRK | 1 | $13.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.